The authors did emphasize that they were not ruling on the overall “clinical efficacy” of hydroxychloroquine with this research. 

The Trump Administration’s main aim is widening consumer access to lower prices.

Researchers wrote that they observed "substantial and increasing disparities in CVD between people with the most resources and the remainder of the U.S. population."

Early this month CMS agreed to reimburse hospitals for using the first AI software to qualify for Medicare’s NTAP mechanism. Healthcare AI watchers have been unpacking the intricacies of the development ever since.

The latest evidence of COVID-19's cardiovascular impact on patients comes from a new imaging study published in the American Journal of Roentgenology.

The subspecialty is poised to help stem the tide of deaths and disability arising from this concern, experts wrote in AJR. 

COVID-19 may present with medium to large arterial and venous macrothrombi of the abdomen and extremities, so radiologists should raise concern for it when identifying thromboembolic abdominopelvic findings.

Advanced MRI and PET imaging have helped confirm suspicions in neuroscience that Parkinson’s is more than one disease.

The study's authors identified dozens of potential new biomarkers, sharing their findings in the Proceedings of the National Academy of Sciences.

Paris-based Gleamer will use the funds to target U.S. FDA clearance for its BoneView AI solution that's already live in 50 hospitals.